Curespec

Curespec announces first installation in China

A major milestone for Curespec and the future of non-invasive hypertension treatment.
Last week, our team completed a successful multi-day visit in Hainan, China, marking the first installation and launch activities of Nephrospec.

The visit included:
🔹 Clinical and operational training for hospital and distributor teams
🔹 Meetings with heads of nephrology, innovation leaders, and government representatives
🔹 In-depth discussions around clinical outcomes, workflow integration, and large-scale deployment potential
🔹 Practical hands-on sessions with hospital teams and operators
🔹 Growing interest from hospitals already preparing for future clinical activity
Interest exceeded expectations:
More than 50 patients already pre-registered following local media exposure
Additional hospitals progressing through approval and procurement processes
Discussions initiated around strategic partnerships, manufacturing, and broader distribution opportunities across China
The momentum around non-invasive renal therapy is growing rapidly, and

we’re proud to see such strong enthusiasm from clinicians, hospitals, and healthcare innovators.

A huge thank you to our partners, hospital teams, and everyone involved in making this visit a success.
The journey is just beginning.

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

We’re excited that Curespec has been selected to attend the 2026 Mayo ClinicMayo Clinic Cardiology & Radiology Innovation Summit in Rochester, Minnesota.

Looking forward to engaging with the Mayo Clinic community and fellow innovators.